Cargando…

Risk and Prognostic Factors in Very Old Patients with Sepsis Secondary to Community-Acquired Pneumonia

Background: Little is known about risk and prognostic factors in very old patients developing sepsis secondary to community-acquired pneumonia (CAP). Methods: We conducted a retrospective observational study of data prospectively collected at the Hospital Clinic of Barcelona over a 13-year period. C...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cillóniz, Catia, Dominedò, Cristina, Ielpo, Antonella, Ferrer, Miquel, Gabarrús, Albert, Battaglini, Denise, Bermejo-Martin, Jesús, Meli, Andrea, García-Vidal, Carolina, Liapikou, Adamanthia, Singer, Mervyn, Torres, Antoni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678833/ https://www.ncbi.nlm.nih.gov/pubmed/31269766 http://dx.doi.org/10.3390/jcm8070961

Ejemplares similares

Severe community-acquired pneumonia: Characteristics and prognostic factors in ventilated and non-ventilated patients
por: Ferrer, Miquel, et al.
Publicado: (2018)

Community-acquired pneumonia in critically ill very old patients: a growing problem
por: Cillóniz, Catia, et al.
Publicado: (2020)

Lymphopenia Is Associated With Poor Outcomes of Patients With Community-Acquired Pneumonia and Sepsis
por: Cilloniz, Catia, et al.
Publicado: (2021)

Lymphocytopenia as a Predictor of Mortality in Patients with ICU-Acquired Pneumonia
por: Ceccato, Adrian, et al.
Publicado: (2019)

Outcomes of Critically Ill Very Old Patients With Community-Acquired Pneumonia and Acute Respiratory Distress Syndrome
por: Cillóniz, Catia, et al.
Publicado: (2022)

Multidrug Resistant Gram-Negative Bacteria in Community-Acquired Pneumonia
por: Cillóniz, Catia, et al.
Publicado: (2019)

PES Pathogens in Severe Community-Acquired Pneumonia
por: Cillóniz, Catia, et al.
Publicado: (2019)

Twenty-year trend in mortality among hospitalized patients with pneumococcal community-acquired pneumonia
por: Cillóniz, Catia, et al.
Publicado: (2018)

Effect of Corticosteroids on C-Reactive Protein in Patients with Severe Community-Acquired Pneumonia and High Inflammatory Response: The Effect of Lymphopenia
por: Torres, Antoni, et al.
Publicado: (2019)

Addendum: Cillóniz, C.; Dominedò, C.; Nicolini, A.; Torres, A. PES Pathogens in Severe Community-Acquired Pneumonia. Microorganisms 2019, 7, 49
por: Cillóniz, Catia, et al.
Publicado: (2019)

Community-acquired polymicrobial pneumonia in the intensive care unit: aetiology and prognosis
por: Cillóniz, Catia, et al.
Publicado: (2011)

Host-targeted approaches to sepsis due to community-acquired pneumonia
por: Cilloniz, Catia, et al.
Publicado: (2022)

Polymicrobial intensive care unit-acquired pneumonia: prevalence, microbiology and outcome
por: Ferrer, Miquel, et al.
Publicado: (2015)

Ceftobiprole for the treatment of pneumonia
por: Cillóniz, Catia, et al.
Publicado: (2019)

Treatment with macrolides and glucocorticosteroids in severe community-acquired pneumonia: A post-hoc exploratory analysis of a randomized controlled trial
por: Ceccato, Adrian, et al.
Publicado: (2017)

Lymphopenic Community Acquired Pneumonia (L-CAP), an Immunological Phenotype Associated with Higher Risk of Mortality
por: Bermejo-Martin, Jesus F., et al.
Publicado: (2017)

Impact of Cefotaxime Non-susceptibility on the Clinical Outcomes of Bacteremic Pneumococcal Pneumonia
por: Cillóniz, Catia, et al.
Publicado: (2019)

Ventilator-Associated Pneumonia and PaO(2)/F(I)O(2) Diagnostic Accuracy: Changing the Paradigm?
por: Ferrer, Miquel, et al.
Publicado: (2019)

Systemic Inflammatory Response and Outcomes in Community-Acquired Pneumonia Patients Categorized According to the Smoking Habit or Presence of Chronic Obstructive Pulmonary Disease
por: Crisafulli, Ernesto, et al.
Publicado: (2020)

Bacterial co-infection with H1N1 infection in patients admitted with community acquired pneumonia
por: Cillóniz, Catia, et al.
Publicado: (2012)

Impact on in-hospital mortality of ceftaroline versus standard of care in community-acquired pneumonia: a propensity-matched analysis
por: Cilloniz, Catia, et al.
Publicado: (2021)

Multidrug Resistant Gram-Negative Bacteria in Community-Acquired Pneumonia
por: Cillóniz, C., et al.
Publicado: (2018)

Promoting the use of social networks in pneumonia
por: Cillóniz, Catia, et al.
Publicado: (2020)

Correction: Promoting the use of social networks in pneumonia
por: Cillóniz, Catia, et al.
Publicado: (2023)

Ceftobiprole for the treatment of pneumonia: a European perspective
por: Liapikou, Adamantia, et al.
Publicado: (2015)

Remdesivir and survival outcomes in critically ill patients with COVID-19: A multicentre observational cohort study
por: Cillóniz, Catia, et al.
Publicado: (2023)

Characteristics and Management of Community-Acquired Pneumonia in the Era of Global Aging
por: Cillóniz, Catia, et al.
Publicado: (2018)

Defining Community-Acquired Pneumonia as a Public Health Threat: Arguments in Favor from Spanish Investigators
por: Cillóniz, Catia, et al.
Publicado: (2020)

Phenotyping community-acquired pneumonia according to the presence of acute respiratory failure and severe sepsis
por: Aliberti, Stefano, et al.
Publicado: (2014)

Ceftaroline in severe community-acquired pneumonia
por: Cilloniz, Catia, et al.
Publicado: (2022)

Readmission for Acute Exacerbation within 30 Days of Discharge Is Associated with a Subsequent Progressive Increase in Mortality Risk in COPD Patients: A Long-Term Observational Study
por: Guerrero, Mónica, et al.
Publicado: (2016)

Biomarkers in sepsis
por: Singer, Mervyn
Publicado: (2013)

Impact of bronchiectasis on outcomes of hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease: A propensity matched analysis
por: Crisafulli, Ernesto, et al.
Publicado: (2018)

Clinical variables predicting the risk of a hospital stay for longer than 7 days in patients with severe acute exacerbations of chronic obstructive pulmonary disease: a prospective study
por: Crisafulli, Ernesto, et al.
Publicado: (2018)

Beta-blockers in sepsis
por: Singer, Mervyn
Publicado: (2019)

Antimicrobial Resistance Among Streptococcus pneumoniae
por: Cillóniz, Catia, et al.
Publicado: (2018)

Epidemiology, etiology, and risk factors of bacterial pneumonia
por: Torres, Antoni, et al.
Publicado: (2015)

Steroid therapy and antiviral treatment in SARSCoV-2 pneumonia: clinical contexts and indications
por: Torres, Antoni, et al.
Publicado: (2022)

A Novel Approach to Temperature Profiling in Relation to Clinical Outcomes in Oncological Patients with Neutropenia
por: Cilloniz, Catia, et al.
Publicado: (2022)

Time to blood culture positivity as a predictor of clinical outcomes and severity in adults with bacteremic pneumococcal pneumonia
por: Cillóniz, Catia, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_9hg657708kkl59onhko9s7c1td